These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 1577476)

  • 1. An error in dystrophin mRNA processing in golden retriever muscular dystrophy, an animal homologue of Duchenne muscular dystrophy.
    Sharp NJ; Kornegay JN; Van Camp SD; Herbstreith MH; Secore SL; Kettle S; Hung WY; Constantinou CD; Dykstra MJ; Roses AD
    Genomics; 1992 May; 13(1):115-21. PubMed ID: 1577476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative dystrophin gene transcripts in golden retriever muscular dystrophy.
    Schatzberg SJ; Anderson LV; Wilton SD; Kornegay JN; Mann CJ; Solomon GG; Sharp NJ
    Muscle Nerve; 1998 Aug; 21(8):991-8. PubMed ID: 9655116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A duchenne muscular dystrophy gene hot spot mutation in dystrophin-deficient cavalier king charles spaniels is amenable to exon 51 skipping.
    Walmsley GL; Arechavala-Gomeza V; Fernandez-Fuente M; Burke MM; Nagel N; Holder A; Stanley R; Chandler K; Marks SL; Muntoni F; Shelton GD; Piercy RJ
    PLoS One; 2010 Jan; 5(1):e8647. PubMed ID: 20072625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The golden retriever model of Duchenne muscular dystrophy.
    Kornegay JN
    Skelet Muscle; 2017 May; 7(1):9. PubMed ID: 28526070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole genome sequencing reveals a 7 base-pair deletion in DMD exon 42 in a dog with muscular dystrophy.
    Nghiem PP; Bello L; Balog-Alvarez C; López SM; Bettis A; Barnett H; Hernandez B; Schatzberg SJ; Piercy RJ; Kornegay JN
    Mamm Genome; 2017 Apr; 28(3-4):106-113. PubMed ID: 28028563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscle function recovery in golden retriever muscular dystrophy after AAV1-U7 exon skipping.
    Vulin A; Barthélémy I; Goyenvalle A; Thibaud JL; Beley C; Griffith G; Benchaouir R; le Hir M; Unterfinger Y; Lorain S; Dreyfus P; Voit T; Carlier P; Blot S; Garcia L
    Mol Ther; 2012 Nov; 20(11):2120-33. PubMed ID: 22968479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cryptic splicing involving the splice site mutation in the canine model of Duchenne muscular dystrophy.
    Fletcher S; Ly T; Duff RM; McC Howell J; Wilton SD
    Neuromuscul Disord; 2001 Apr; 11(3):239-43. PubMed ID: 11297938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRI roadmap-guided transendocardial delivery of exon-skipping recombinant adeno-associated virus restores dystrophin expression in a canine model of Duchenne muscular dystrophy.
    Barbash IM; Cecchini S; Faranesh AZ; Virag T; Li L; Yang Y; Hoyt RF; Kornegay JN; Bogan JR; Garcia L; Lederman RJ; Kotin RM
    Gene Ther; 2013 Mar; 20(3):274-82. PubMed ID: 22551778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antisense oligonucleotide-induced exon skipping restores dystrophin expression in vitro in a canine model of DMD.
    McClorey G; Moulton HM; Iversen PL; Fletcher S; Wilton SD
    Gene Ther; 2006 Oct; 13(19):1373-81. PubMed ID: 16724091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repression of phosphatidylinositol transfer protein α ameliorates the pathology of Duchenne muscular dystrophy.
    Vieira NM; Spinazzola JM; Alexander MS; Moreira YB; Kawahara G; Gibbs DE; Mead LC; Verjovski-Almeida S; Zatz M; Kunkel LM
    Proc Natl Acad Sci U S A; 2017 Jun; 114(23):6080-6085. PubMed ID: 28533404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vivo Evaluation of Multiple Exon Skipping with Peptide-PMOs in Cardiac and Skeletal Muscles in Dystrophic Dogs.
    Maruyama R; Aoki Y; Takeda S; Yokota T
    Methods Mol Biol; 2018; 1828():365-379. PubMed ID: 30171554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of the dog model for Duchenne muscular dystrophy in gene therapy trials.
    Howell JM; Fletcher S; Kakulas BA; O'Hara M; Lochmuller H; Karpati G
    Neuromuscul Disord; 1997 Jul; 7(5):325-8. PubMed ID: 9267846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. X-linked muscular dystrophy in a Labrador Retriever strain: phenotypic and molecular characterisation.
    Barthélémy I; Calmels N; Weiss RB; Tiret L; Vulin A; Wein N; Peccate C; Drougard C; Beroud C; Deburgrave N; Thibaud JL; Escriou C; Punzón I; Garcia L; Kaplan JC; Flanigan KM; Leturcq F; Blot S
    Skelet Muscle; 2020 Aug; 10(1):23. PubMed ID: 32767978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges associated with homologous directed repair using CRISPR-Cas9 and TALEN to edit the DMD genetic mutation in canine Duchenne muscular dystrophy.
    Mata López S; Balog-Alvarez C; Vitha S; Bettis AK; Canessa EH; Kornegay JN; Nghiem PP
    PLoS One; 2020; 15(1):e0228072. PubMed ID: 31961902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation segregation and rapid carrier detection of X-linked muscular dystrophy in dogs.
    Bartlett RJ; Winand NJ; Secore SL; Singer JT; Fletcher S; Wilton S; Bogan DJ; Metcalf-Bogan JR; Bartlett WT; Howell JM; Cooper BJ; Kornegay JN
    Am J Vet Res; 1996 May; 57(5):650-4. PubMed ID: 8723876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of the six-minute walk test to characterize golden retriever muscular dystrophy.
    Acosta AR; Van Wie E; Stoughton WB; Bettis AK; Barnett HH; LaBrie NR; Balog-Alvarez CJ; Nghiem PP; Cummings KJ; Kornegay JN
    Neuromuscul Disord; 2016 Dec; 26(12):865-872. PubMed ID: 27818009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel point mutation (G-1 to T) in a 5' splice donor site of intron 13 of the dystrophin gene results in exon skipping and is responsible for Becker muscular dystrophy.
    Hagiwara Y; Nishio H; Kitoh Y; Takeshima Y; Narita N; Wada H; Yokoyama M; Nakamura H; Matsuo M
    Am J Hum Genet; 1994 Jan; 54(1):53-61. PubMed ID: 8279470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo targeted repair of a point mutation in the canine dystrophin gene by a chimeric RNA/DNA oligonucleotide.
    Bartlett RJ; Stockinger S; Denis MM; Bartlett WT; Inverardi L; Le TT; thi Man N; Morris GE; Bogan DJ; Metcalf-Bogan J; Kornegay JN
    Nat Biotechnol; 2000 Jun; 18(6):615-22. PubMed ID: 10835598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interplay between exonic splicing enhancers, mRNA processing, and mRNA surveillance in the dystrophic Mdx mouse.
    Buvoli M; Buvoli A; Leinwand LA
    PLoS One; 2007 May; 2(5):e427. PubMed ID: 17487273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel canine model for Duchenne muscular dystrophy (DMD): single nucleotide deletion in DMD gene exon 20.
    Mata López S; Hammond JJ; Rigsby MB; Balog-Alvarez CJ; Kornegay JN; Nghiem PP
    Skelet Muscle; 2018 May; 8(1):16. PubMed ID: 29843823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.